Sonographic Measurement of Mesenteric Fat Thickness Is a Better Predictor of Aortic Stiffness Compared With Conventional Obesity Indexes

Liu, Kin Hung; Kong, Alice Pik Shan; Chan, Juliana C.N.; Chu, Wing Hong

doi:10.1016/j.ultrasmedbio.2022.10.016

Cited by 1 publication

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To our knowledge, there are no previous studies which investigated the changes of mesenteric fat in bariatric surgery. However, in the past 2 years, there has been five studies on mesenteric fat 11–15 . Thus, the aim of this study was to investigate the associations of the changes of abdominal fat thicknesses with changes of anthropometric indexes and improvements of metabolic phenotypes in patients with co‐existing obesity and T2DM.…”

Section: Introductionmentioning

confidence: 99%

Changes in mesenteric fat thickness and its clinical impact in bariatric surgery

Chiyanika,

Cheung,

Liu

et al. 2023

Clinical Obesity

Self Cite

View full text Add to dashboard Cite

SummaryObesity, especially central obesity is associated with increased risk of metabolic syndrome, non‐alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus. The study aimed to investigate the associations of the changes of abdominal fat thicknesses with changes of anthropometric indexes and improvements of metabolic phenotypes in patients with obesity and T2DM before and after bariatric surgery. Between April 2016 and January 2017, 34 adult patients with concurrent obesity and T2DM scheduled for different bariatric surgeries were prospectively evaluated by ultrasound before and 1‐year after bariatric surgery to determine abdominal fat thicknesses (mesenteric fat, preperitoneal fat and subcutaneous fat) and NAFLD. At 1 year, of the 25 patients that finished the study, significant decrease in mesenteric‐fat‐thickness was associated with significant reduction of obesity, that is, BMI (−24%, p < .001), remission of metabolic syndrome (32%, p = .008), NAFLD (60%, p < .001) and T2DM (44%, p < .001). Lower baseline mesenteric fat thickness was associated with remission of metabolic syndrome. Lower baseline mesenteric‐fat‐thickness may have the potential to predict metabolic syndrome remission after bariatric surgery.

show abstract

Section: Introductionmentioning

confidence: 99%